Study of Mortality in a Urology Department: A Case of the Urology Department of the Cocody University Hospital ()
1. Introduction
Mortality is the study of deaths and their evolution in a population [1]. Its study in a hospital department allows for a control and revision of therapeutic measures. In the literature, several studies on hospital mortality have been carried out in paediatrics, gynaecology and obstetrics and in infectious disease departments [2].
Relatively few studies have been performed on in-hospital mortality in urology. In Côte d’Ivoire, Dékou et al. had carried out the last study on mortality in urology in 2009 [3].
The aim of this work was to estimate the mortality rate and to identify the main causes of death in urology.
2. Patients and Methods
This was a retrospective descriptive study carried out in the Urology Department of the Cocody University Hospital over a period of 22 years, from January 1, 2000 to December 31, 2021.
The sample consisted only of patients who died during hospitalization in the department during the study period. Data were collected from the hospitalization register, the urology department’s death register, and deceased patient records.
The parameters evaluated were essentially the age and sex of the deceased patients; clinical diagnosis, comorbidity factors, and causes of death. The data analysis was done by SPSS 16.0 software.
3. Result
2593 patients were hospitalized during the study period and 548 deaths were recorded.
3.1. Distribution of Deaths by Year
Table 1. Distribution of patient deaths by year.
Year |
Hospitalized |
Deceased |
Percentage (%) |
2000 |
132 |
28 |
21.21 |
2001 |
16 |
3 |
18.75 |
2002 |
34 |
7 |
20.59 |
2003 |
18 |
4 |
22.22 |
2004 |
34 |
7 |
20.59 |
2005 |
130 |
27 |
20.77 |
2006 |
26 |
5 |
19.23 |
2007 |
60 |
13 |
21.66 |
2008 |
26 |
5 |
19.23 |
2009 |
86 |
18 |
20.93 |
2010 |
60 |
13 |
21.66 |
2011 |
111 |
24 |
21.62 |
2012 |
60 |
13 |
21.66 |
2013 |
267 |
56 |
20.97 |
2014 |
407 |
86 |
21.13 |
2015 |
267 |
56 |
20.97 |
2016 |
52 |
11 |
21.15 |
2017 |
70 |
15 |
21.43 |
2018 |
301 |
64 |
21.26 |
2019 |
67 |
14 |
20.89 |
2020 |
52 |
11 |
21.15 |
2021 |
319 |
67 |
21.00 |
Total |
2593 |
548 |
21.13 |
The highest number of deaths was recorded in 2014, with 86 deaths and an overall mortality rate of 21.13% (Table 1).
3.2. Age
The average age of patients who died was 68 years.
Figure 1. Distribution of deceased patients by group of age.
Average age was 65.82 years; Median was 68 years; Standard deviation was 12.714; minimum = 21 years old; maximum = 89 years. Patients aged 51 to 80 years (78.8%) predominated with two peaks in the [61 - 70] and [71 - 80] brackets with 34.8% and 29.5% respectively (Figure 1).
3.3. Sex
Male gender was dominated with sex-ratio of 12.7 males for a female (Figure 2).
Figure 2. Distribution of patients according to sex.
3.4. Comorbidity Factors
Cancer was the first responsible of death in this study (Table 2).
Table 2. Distribution of patients according to comorbidity factors.
Pathology |
Numbers |
Percentage (%) |
Prostate cancer + Hypertension |
41 |
33.06 |
Benign prostate hyperplasia + hypertension |
15 |
12.09 |
Bladder cancer + hypertension |
30 |
24.19 |
Ureteral stricture + HIV |
9 |
7.26 |
Fournier gangrene + Diabetes |
19 |
15.32 |
Fournier gangrene + Hiv |
103 |
8.06 |
Total |
124 |
100 |
3.5. Mortality per Pathology
Table 3. Distribution of patients according to the cause of death.
Pathology |
Numbers of Deceased |
Numbers Hospitalized |
Percentage (%) |
Prostate cancer |
305 |
1084 |
28.14 |
Penile fracture |
0 |
21 |
0 |
Benign prostate hyperplasia |
59 |
575 |
10.80 |
Ureteral stricture |
19 |
162 |
11.72 |
Kidney abscess |
0 |
13 |
0 |
Ectopic testicular |
0 |
4 |
0 |
Vescio-vagina fistular |
0 |
8 |
0 |
Inguinal hernia |
2 |
4 |
50 |
Hydrocele |
0 |
8 |
0 |
Renal calculus |
0 |
1 |
0 |
Ureteric calculus |
1 |
63 |
1.59 |
Fournier gangrene |
39 |
134 |
29.10 |
Orchitis |
0 |
56 |
0 |
Priapism |
0 |
142 |
0 |
Prostatitis |
0 |
16 |
0 |
Pyelonephritis |
0 |
4 |
0 |
Ureteral stricture |
0 |
8 |
0 |
Testicular torsion |
0 |
13 |
0 |
Renal tumor |
19 |
92 |
20.65 |
Testicular tumor |
8 |
8 |
100 |
Bladder tumor |
96 |
178 |
53.63 |
Total |
548 |
2593 |
21.13 |
Infection disease was represented by Fournier gangrene with 29.10% (Table 3).
3.6. Mortality
Table 4. Distribution of patients according to pathology.
Pathologie |
Numbers |
Percentage (%) |
Rank |
Prostate cancer |
305 |
55.66 |
1 |
Bladder cancer |
96 |
17.52 |
2 |
Benign prostate hyperplasia |
59 |
10.77 |
3 |
Fournier gangrene |
39 |
7.12 |
4 |
Uretral stenosis |
19 |
3.46 |
5 |
Renal tumor |
19 |
3.46 |
5 |
Testicular cancer |
8 |
1.46 |
7 |
Inguinale hernia |
2 |
0.36 |
8 |
Ureteral calculus |
1 |
0.18 |
9 |
Total |
548 |
100 |
|
Prostate cancer was responsible of the highest rate of mortality. It was followed by bladder cancer (Table 4).
3.7. Mortality Due to Cancerous Pathology
Pathology of cancer was responsible of 78.10% of death (Table 5).
Table 5. Distribution of patients according to cancerous pathology.
Pathology |
Numbers |
Percentage (%) |
Rank |
Prostate cancer |
305 |
71.26 |
1 |
Bladder cancer |
96 |
22.43 |
2 |
Renal cancer |
19 |
4.44 |
3 |
Testicular cancer |
8 |
1.87 |
4 |
Total |
428 |
100 |
|
3.8. Mortality Due to Non-Cancerous Conditions
Non-cancer pathologies were responsible of 21.90% of death (Table 6).
Table 6. Distribution of patients according to non-cancerous condition.
Pathology |
Numbers |
Percentage (%) |
Rank |
Benign prostate hyperplasia |
59 |
49.17 |
1 |
Fournier gangrene |
39 |
32.5 |
2 |
Ureteral stenosis |
19 |
15.83 |
3 |
Inguinal hernia |
2 |
1.66 |
4 |
Renal calculus |
1 |
0.83 |
5 |
Total |
120 |
100 |
|
4. Comment
During the study period, 2593 patients were hospitalized and 548 were deceased, i.e., a hospital mortality of 21.13%. Mortality per year showed a high incidence in 2003 of 22.22%.
Siné et al., in Senegal, had observed a hospital mortality of 2.9% over a period of 6 years [4].
Our study period was 20 years, which is more than 3 times the length of Sine et al.’s study period. The long period could explain the difference in hospital mortality. In addition, Côte d’Ivoire experienced the military-political crisis in 2022 and the post-electoral crisis in 2010. During these crises, the dysfunction of health systems, the lack of quality health care workers contributed to the increase in mortality in our study.
The mean age of the patients who died was 65.8 (or 68? to be verified) years.
Siné et al. had found an average age of 63.6 in 2016 in Senegal [4], which was more or less equal to ours.
Takangno et al. had observed an average age of 43 years [5].
Takangno et al.’s study was carried out in a general surgery department where many pathologies develop in subjects before the age of 50. In urology, the majority of pathologies that cause death occur after the age of 50.
The male sex predominated in our study with a sex-ratio of 12.7 men to one woman. Our result was similar to that of Dembélé et al., who had observed a sex ratio of 17.8 men to one woman [6].
Generally speaking, urology departments are more frequented by men. Indeed, urology treats disorders of the urinary and genital tract of men. While for women, it only treats urinary tract conditions. In addition, prostate cancer was the leading cause of death. This pathology is only observed in men.
Comorbidity factors were dominated by hypertensives.
This pathology is becoming more and more common in the general population.
Hamza had observed smoking as the most common comorbidity factor [7].
This difference is due to the fact that Hamza’s study was carried out in Morocco, where the population has a high propensity to consume tobacco, as in other Maghreb countries.
Urogenital cancers were responsible for 78.1% of deaths. Siné et al., in their study, 56% of deaths were due to urological cancer [4]. In Hamza’s study in Morocco, urological cancers were responsible for 60% of deaths [7]. In some developed countries, urogenital cancers were the leading cause of death in urology [8]-[10].
The high mortality of urological cancers in our context could be explained by the fact that diagnosis is usually made at the metastatic stage. Many patients consulted late in our context. Patients only come to hospital if symptoms persist or worsen.
Prostate cancer was the leading cause of death with 71.26%, followed by bladder cancer with 22.43% and kidney cancer with 4.44%. In Senegal, Siné et al. had prostate cancer [4]. In the literature, several studies have observed prostate cancer as the leading cause of death [11] [12].
Non-cancerous conditions were responsible for 18% of deaths. Benign prostatic hyperplasia accounted for 49.17% followed by Fournier gangrene with 32.5%. This result was comparable to that of Siné et al. in Senegal [4].
BPH was the leading cause of hospitalization. It was the leading cause of death from non-cancerous diseases. It was BPH complicated by abundant hematuria with a state of hemorrhagic shock. The unavailability of products, generally due to the impoverishment of the population, caused the death of these patients. This reveals the shortage of blood products in the Ivorian health system.
Sometimes the death was related to ionic disorders (dyskalemia, dysnatremia) caused by obstructive renal insufficiency, which sometimes complicated benign prostatic hyperplasia.
Fournier gangrene was the only cause of death related to infectious diseases. It represented 23%. In Bakayoko’s study, this condition did not cause death. Deaths of infectious origin accounted for 68%, mainly due to urinary phlegmon of the bursa [6].
In the contemporary literature, causes of infectious origin were 68% [13] [14].
Sepsis and subsequently septic shock caused the death of patients. In the emergency departments, due to a lack of good resuscitation, these patients died in the preoperative period.
5. Conclusions
Hospital mortality in our context remains high compared to developed countries. Urological cancers were responsible for more than 70% of cases. Prostate cancer remains the leading cause of death at Urology Department of the CHU of Cocody. Thus, the need to organize screening campaigns for people above 50 years in order to have an early diagnosis of localized prostate cancer. Which have curative treatment.
Though our study was carried out in the largest Urology Department of Côte d’Ivoire, it was a limited fact that there are two of those departments. Thus, there is a need to extend our study.